GILEAD SCIENCES, INC. — Director's Dealing 2018

Mar 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-03-01

Reporting Person: MARTIN JOHN C (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-01	Common Stock	M	50000	$23.60	Acquired	3067762	Direct
2018-03-01	Common Stock	S	16902	$77.8401	Disposed	3050860	Direct
2018-03-01	Common Stock	S	26575	$78.9539	Disposed	3024285	Direct
2018-03-01	Common Stock	S	6523	$79.4913	Disposed	3017762	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-01	Non-qualified Stock Option (Right to Buy)	$23.60	M	50000	Disposed	2019-01-21	Common Stock (50000)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: Sale prices reported for the transactions reported here range from $77.33 to $78.32. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $78.35 to $79.35. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F5: Sale prices reported for the transactions reported here range from $79.36 to $79.74. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.